BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24761791)

  • 1. A review of the management of childhood immune thrombocytopenia: how can we provide an evidence-based approach?
    Cooper N
    Br J Haematol; 2014 Jun; 165(6):756-67. PubMed ID: 24761791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in the diagnosis and management of childhood acute immune thrombocytopenic purpura.
    Segel GB; Feig SA
    Pediatr Blood Cancer; 2009 Sep; 53(3):318-24. PubMed ID: 19165890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults.
    George JN
    Curr Hematol Rep; 2003 Sep; 2(5):381-7. PubMed ID: 12932309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Thrombocytopenia in Children: Consensus and Controversies.
    Singh G; Bansal D; Wright NAM
    Indian J Pediatr; 2020 Feb; 87(2):150-157. PubMed ID: 31927692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding severity as an important outcome in childhood immune thrombocytopenia.
    Flores A; Buchanan GR
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S8-11. PubMed ID: 23109508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study.
    Pansy J; Minkov M; Dengg R; Quehenberger F; Lackner H; Nebl A; Sovinz P; Schwinger W; Urban C; Benesch M
    Klin Padiatr; 2010 Nov; 222(6):374-7. PubMed ID: 21058224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune thrombocytopenia.
    Maher GM
    S D Med; 2014 Oct; 67(10):415-7. PubMed ID: 25423768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune thrombocytopenic purpura: the treatment paradigm.
    Stasi R
    Eur J Haematol Suppl; 2009 Mar; (71):13-9. PubMed ID: 19200303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of immune thrombocytopenia in childhood.
    Kühne T
    Hamostaseologie; 2017 Jan; 37(1):36-44. PubMed ID: 27699328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
    Schiavotto C; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS; Carcao M
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controversies in the treatment of paediatric immune thrombocytopenia].
    Berrueco R; Dapena JL; Sebastián E; Sastre A
    An Pediatr (Engl Ed); 2018 Sep; 89(3):189.e1-189.e8. PubMed ID: 30033108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating bleeding severity in immune thrombocytopenia (ITP).
    Neunert CE
    Ann Hematol; 2010 Jul; 89 Suppl 1():47-50. PubMed ID: 20309688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of immune thrombocytopenic purpura in children.
    Tarantino MD; Bolton-Maggs PH
    Curr Opin Hematol; 2007 Sep; 14(5):526-34. PubMed ID: 17934363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia.
    Laws HJ; Janssen G; Borkhardt A
    Hamostaseologie; 2009 May; 29(2):171-6. PubMed ID: 19404521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis.
    Buchanan GR; Journeycake JM; Adix L
    Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of chronic idiopathic thrombocytopenic purpura in children.
    Bansal D; Bhamare TA; Trehan A; Ahluwalia J; Varma N; Marwaha RK
    Pediatr Blood Cancer; 2010 Mar; 54(3):403-7. PubMed ID: 19908301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.